These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 539451)

  • 1. Screening pharmacological studies of four dihydroisoquinoline derivatives.
    Stoychev T; Koleva M; Orahovats A; Trifonov L
    Acta Physiol Pharmacol Bulg; 1979; 5(3):82-90. PubMed ID: 539451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropharmacological activity of newly-synthethized derivatives of 3,3-diethyl-2,4-pyridinedione. III. N-Acyl derivatives of 3,3-diethyl-2,4-pyridinedione.
    Belcheva I; Stoychev T; Karadjov K; Danchev D
    Acta Physiol Pharmacol Bulg; 1979; 5(3):75-81. PubMed ID: 539450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental pharmacological study of three species from genus Salvia.
    Todorov S; Philianos S; Petkov V; Harvala C; Zamfirova R; Olimpiou H
    Acta Physiol Pharmacol Bulg; 1984; 10(2):13-20. PubMed ID: 6485822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropharmacological activity of new derivatives of 3,3-diethyl-2,4-pyridinedione. IV. 1-alkyl derivatives of 3,3-diethyl-2,4-pyridinedione.
    Beltcheva I; Stoytchev T; Danchev D; Karadjov K
    Acta Physiol Pharmacol Bulg; 1979; 5(4):44-50. PubMed ID: 543411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [General pharmacologic studies on the analgesic flupirtine].
    Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
    Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solvent artifacts likely to be induced by dimethylformamide.
    Varma RK; Kaushal R; Thomas GP; Tripathi RM; Junnarkar AY; Singh PP
    Indian J Physiol Pharmacol; 1986; 30(3):248-54. PubMed ID: 3557612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacological activity of newly-synthesized derivatives of 3,3-diethyl-2,4-pyridinedione. V. Relation between chemical structure and pharmacological activity.
    Belcheva I; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1983; 9(4):37-47. PubMed ID: 6677062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacology of some 1,3-dioxolanes, 1,3-oxathiolanes and 1,3-dithiolanes].
    Bekemeier H; Köster D
    Pharmazie; 1976; 31(5):317-23. PubMed ID: 959287
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the effect of urapidil on the central nervous system and various organ functions in animal experiments (author's transl)].
    Schoetensack W; Eltze M; Gönne S; Kley KP; Menge HG; Müller H
    Arzneimittelforschung; 1977; 27(10):1898-907. PubMed ID: 579100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacological properties of muroctasin.
    Kojima H; Hirohashi M; Kasai Y; Takasuna K; Fukumoto C; Akashi A
    Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on pharmacological properties of hexadiphane, oxazepam hemisuccinate and of their combination.
    Babbini M; Torrielli MV
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):311-23. PubMed ID: 4403034
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological studies on the venomous spotted butterfish (Scatophagus argus Linn) sting extract on experimental animals.
    Muhuri D; Karmakar S; Dasgupta SC; Nagchaudhuri AK; Gomes A
    Indian J Exp Biol; 2004 May; 42(5):461-7. PubMed ID: 15233469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evaluation of delta2, 1,2,4-triazolin-5-one [1,3(4-m-chlorophenyl-1-piperazinyl)-propyl]-3,4-diethyl-hydrochloride (Etoperidone), a new potential antidepressant drug.
    Ramacci MT; Ghirardi O; Maccari F; Pacifici L; Sale P
    Arzneimittelforschung; 1979; 29(2):294-307. PubMed ID: 582144
    [No Abstract]   [Full Text] [Related]  

  • 17. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitussive activity and other related pharmacological properties of d-3-methyl-N-methylmorphinan (AT-17).
    Kasé Y; Kito G; Miyata T; Uno T; Takahama K; Ida H
    Arzneimittelforschung; 1976; 26(3):353-60. PubMed ID: 989326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacology of potential antidepressants of the N-L-phenylalanyl-beta-phenylalkylamine class].
    Beck D; Fink K; Hölzl J; Krieglstein J; Petter A; Rieger H; Schönenberger H
    Arzneimittelforschung; 1983; 33(3):404-10. PubMed ID: 6683515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.